Computer-aided detection (CAD) firm iCAD has received U.S. Food and Drug Administration (FDA) clearance for its VeraLook CAD offering for virtual colonoscopy (also known as CT colonography or CTC) exams.
Now commercially available in the U.S., VeraLook was introduced in Europe last year by the Nashua, NH-based firm.
Related Reading
iCAD posts gain in Q2 revenues, July 29, 2010
iCAD debuts new MRI software, July 20, 2010
iCAD wins government contract, June 10, 2010
iCAD to launch CTC CAD software, May 27, 2010
iCAD revenue slips in Q1, April 29, 2010
Copyright © 2010 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
